Removing fibroids can prevent recurrent miscarriage

Article

Surgical removal of fibroids that distort the uterine cavity reduced the risk of second-trimester miscarriage to zero in a new study that also found solid evidence linking fibroids to recurrent miscarriage (ie, 3 or more consecutive miscarriages). MORE

Surgical removal of fibroids that distort the uterine cavity reduced the risk of second-trimester miscarriage to zero in a new study that also found solid evidence linking fibroids to recurrent miscarriage (ie, 3 or more consecutive miscarriages).

The study, which was published online September 28 in Human Reproduction, analyzed retrospective and prospective data from 966 women referred to a recurrent miscarriage clinic in Sheffield, United Kingdom. Researchers diagnosed fibroids in 79 women using combined transvaginal ultrasound and hysterosalpingography and removed uterine cavity-distorting (submucosal) fibroids from 25 women by hysteroscopy. Fifty-four women with nondistorting (intramural or subserosal) fibroids and a matched control group of 285 women with unexplained recurrent miscarriages had no intervention. Among the 25 women whose fibroids were removed, subsequent second-trimester miscarriage rates fell from 21.7% to 0%, (P<0.01) raising the live birth rate from 23.3% to 52%.

In addition, the study enabled researchers to calculate the prevalence of fibroids among women with recurrent miscarriages at 8.2% (79/966).

The 54 women with non-distorting fibroids achieved a live birth rate of 70.4% without intervention after referral to the clinic, compared with a 20.6% live birth rate before referral. The second-trimester miscarriage rate in this group dropped from 17.6% to 0%. These results were similar to results for the control group.

The researchers recommend offering hysteroscopic surgery to women with uterine-distorting fibroids who have suffered 1 or more second-trimester miscarriages but not to women with intramural or subserosal fibroids. A limitation of the study is lack of a control group for women who underwent surgery to remove fibroids, which precluded determining how the women would have fared without surgery.

Read other articles in this issue of Special Delivery.

Recent Videos
First US national HPV conference highlights advances in cancer prevention | Image Credit: uchealth.com.
Mitchell Creinin, MD, reports estetrol pill eases menstrual symptoms | Image Credit: health.ucdavis.edu
1 expert is featured in this series.
Susanna Mitro, PhD, reveals ethnic disparities in uterine fibroid diagnosis | Image Credit: divisionofresearch.kaiserpermanente.org.
Shayna Mancuso, DO, highlights the real impact of menopause | Image Credit: linkedin.com.
Jihong Liu, ScD, explains how to improve perinatal outcomes in COVID patients | Image Credit: sc.edu.
1 expert is featured in this series.
Jihong Liu, ScD, highlights adverse perinatal outcomes linked to the COVID pandemic | Image Credit: sc.edu.
Experts highlight infant health benefits from minor diet changes in pregnancy | Image Credit: ohsu.edu.
Connie Stark, RNC, PNC, provides fertility preservation insights for endometriosis patients | Image Credit: linkedin.com.
Related Content
© 2025 MJH Life Sciences

All rights reserved.